Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Blood Sample

Research Leaders

5 sponsors active, led by Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Blood Sample1
  • 24 Hr Urine Samples1
  • Blood Samples1
  • Neuro Cognitive Tests1
  • Questionnaires On Quality Of Life1

Active Sponsors

  • Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques1
  • University of Aarhus1
  • Hospices Civils de Lyon1
  • Dacima Consulting1
  • F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore1

Top Investigators

Related Conditions

  • Hypoparathyroidism4
  • Adult Children1
  • Albright Syndrome1
  • Hyperparathyroidism1
  • Fibrous Dysplasia1

Activity Timeline